Selection Process of Measures for Core Outcome Set Should Utilize the Highest Methodology Level and Should Be Maximally Free of Bias. Comment on ‘idqol, CDLQI and the 45‐item CADIS Received a Sufficient Content Validity Rating During the HOME VII Meeting in Japan: a Group Discussion Study’

Journal of the European Academy of Dermatology and VenereologyVolume 35, Issue 3 p. e208-e209 Letter to the Editor Selection process of measures for core outcome set should utilize the highest methodology level and should be maximally free of bias. Comment on ‘IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan: a group discussion study’ P.V. Chernyshov, Corresponding Author chernyshovpavel@ukr.net orcid.org/0000-0001-7275-4651 Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine Correspondence: P.V. Chernyshov. E-mail: chernyshovpavel@ukr.netSearch for more papers by this authorL. Tomas Aragones, orcid.org/0000-0001-5891-628X Department of Psychology, University of Zaragoza, Zaragoza, SpainSearch for more papers by this authorC.M. Salavastru, Paediatric Dermatology Discipline, “Carol Davila” University of Medicine and Pharmacy & Colentina Clinical Hospital, Bucharest, RomaniaSearch for more papers by this authorF. Sampogna, orcid.org/0000-0002-7624-3290 Clinical Epidemiology Unit, IDI-IRCCS, Rome, ItalySearch for more papers by this authorM.J. Boffa, Department of Dermatology, Sir Paul Boffa Hospital, Floriana, MaltaSearch for more papers by this authorF. Poot, Department of Dermatology, University Hospital Erasme, Brussels, BelgiumSearch for more papers by this authorV. Bettoli, orcid.org/0000-0002-2760-4600 Department of Medical Sciences, Section of Dermatology, University of Ferrara, Ferrara, ItalySearch for more papers by this authorN. Pustišek, Medical School, Children’s Hospital Zagreb, University of Zagreb, Zagreb, CroatiaSearch for more papers by this authorA.W.M. Evers, Health, Medical, and Neuropsychology unit, Leiden University, Leiden, The NetherlandsSearch for more papers by this authorA. Bewley, Whipps Cross University Hospital, London, UK Queen Mary University Medical School, London, UKSearch for more papers by this authorS.E. Marron, Department of Dermatology, Aragon Psychodermatology Research Group (GAI+PD), University, Hospital Miguel Servet, Zaragoza, SpainSearch for more papers by this authorD. Abeni, Clinical Epidemiology Unit, IDI-IRCCS, Rome, ItalySearch for more papers by this authorA. Svensson, orcid.org/0000-0002-2821-7418 Department of Dermatology and Venereology, Skane University Hospital, Malmö, SwedenSearch for more papers by this authorJ.S. Szepietowski, orcid.org/0000-0003-0766-6342 Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, PolandSearch for more papers by this author P.V. Chernyshov, Corresponding Author chernyshovpavel@ukr.net orcid.org/0000-0001-7275-4651 Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine Correspondence: P.V. Chernyshov. E-mail: chernyshovpavel@ukr.netSearch for more papers by this authorL. Tomas Aragones, orcid.org/0000-0001-5891-628X Department of Psychology, University of Zaragoza, Zaragoza, SpainSearch for more papers by this authorC.M. Salavastru, Paediatric Dermatology Discipline, “Carol Davila” University of Medicine and Pharmacy & Colentina Clinical Hospital, Bucharest, RomaniaSearch for more papers by this authorF. Sampogna, orcid.org/0000-0002-7624-3290 Clinical Epidemiology Unit, IDI-IRCCS, Rome, ItalySearch for more papers by this authorM.J. Boffa, Department of Dermatology, Sir Paul Boffa Hospital, Floriana, MaltaSearch for more papers by this authorF. Poot, Department of Dermatology, University Hospital Erasme, Brussels, BelgiumSearch for more papers by this authorV. Bettoli, orcid.org/0000-0002-2760-4600 Department of Medical Sciences, Section of Dermatology, University of Ferrara, Ferrara, ItalySearch for more papers by this authorN. Pustišek, Medical School, Children’s Hospital Zagreb, University of Zagreb, Zagreb, CroatiaSearch for more papers by this authorA.W.M. Evers, Health, Medical, and Neuropsychology unit, Leiden University, Leiden, The NetherlandsSearch for more papers by this authorA. Bewley, Whipps Cross University Hospital, London, UK Queen Mary University Medical School, London, UKSearch for more papers by this authorS.E. Marron, Department of Dermatology, Aragon Psychodermatology Research Group (GAI+PD), University, Hospital Miguel Servet, Zaragoza, SpainSearch for more papers by this authorD. Abeni, Clinical Epidemiology Unit, IDI-IRCCS, Rome, ItalySearch for more papers by this authorA. Svensson, orcid.org/0000-0002-2821-7418 Department of Dermatology and Venereology, Skane University Hospital, Malmö, SwedenSearch for more papers by this authorJ.S. Szepietowski, orcid.org/0000-0003-0766-6342 Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, PolandSearch for more papers by this author First published: 04 September 2020 https://doi.org/10.1111/jdv.16921Citations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume35, Issue3March 2021Pages e208-e209 RelatedInformation